Théa Pharmaceuticals launches product to relieve dry eye symptoms
Manufacturer Théa Pharmaceuticals has announced the launch of a new product to provide long-lasting relief for those affected by dry eyes.
Théa Pharmaceuticals launched TheaLipid eye drops last month, marking the newest addition to the company’s preservative-free dry eye care range.
The product is clinically proven to provide long-lasting relief from symptoms of dry eye disease, meibomian gland dysfunction (MGD) and blepharitis, the manufacturer said.
The product works with a "three-in-one formula" containing natural soybean phospholipids, medium-chain triglycerides and glycerol to lubricate, restore and stabilise the tear film. This combination restores and protects the lipid layer, controls tear evaporation and provides long-lasting relief of dry eye symptoms, Théa Pharmaceuticals said.
Head of UK marketing at Théa Pharmaceuticals, Dr Matthew Olsen, said: “Eye conditions including dry eye disease and MGD can be painful and have a huge impact on a patient’s daily life.”
“The product's composition is designed to support patients and alleviate a range of eye conditions and symptoms,” he continued.
TheaLipid has a recommended retail price of £15.49.
To order, contact your local Théa area sales manager, call 01782 381698 or email [email protected]. For further education on MGD or other eye conditions visit www.thea-pharmaceuticals.co.uk/academy.
